Tirzepatide vs Semaglutide vs Retatrutide

A research-framed comparison of the GLP-1 cluster: what research teams evaluate, with links to each guide and COA-backed listing.

Comparing the GLP-1 research cluster

Researchers evaluating GLP-1-class compounds frequently weigh Tirzepatide, Semaglutide, and Retatrutide against one another. This page compares the characteristics research teams assess – not human-use outcomes – and links to each single-compound guide and its COA-backed listing.

Side-by-side (research characteristics)

Characteristic	Tirzepatide (H-(T))	Semaglutide (H-(S))	Retatrutide (H-(R))
Receptor class studied	Dual-receptor	Single-receptor	Triple-receptor
Typical research form	Lyophilized	Lyophilized	Lyophilized
COA / documentation	Batch-specific	Batch-specific	Batch-specific
Hydro listing	30 mg →	10 mg →	20 mg →

Characteristics reflect research documentation only. Nothing here describes human use.

Read the full guides

Request the current research catalog

Need a broader view of Hydro’s current research compounds? Request the current catalog and availability list.

Request catalog

Sourcing at volume?

For repeat purchasing or larger-volume research needs, request wholesale pricing and availability.

Request wholesale pricing